Joeri Lambrecht
Overview
Explore the profile of Joeri Lambrecht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
519
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laschtowitz A, Lambrecht J, Puengel T, Tacke F, Mohr R
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982370
Chemokines or chemotactic cytokines play a pivotal role in the immune pathogenesis of liver cirrhosis and hepatocellular carcinoma (HCC). Nevertheless, comprehensive cytokine profiling data across different etiologies of liver diseases...
2.
Geisler L, Hellberg T, Lambrecht J, Jann H, Knorr J, Eschrich J, et al.
J Clin Med
. 2022 Oct;
11(20).
PMID: 36294509
Background and aims: Inflammatory cytokines represent diagnostic and prognostic biomarkers in manifold cancers. Recent data suggest a pivotal role of these cytokines in different biological processes involved in the development...
3.
Shroff T, Aina K, Maass C, Cipriano M, Lambrecht J, Tacke F, et al.
Open Biol
. 2022 Mar;
12(3):210333.
PMID: 35232251
Non-clinical models to study metabolism including animal models and cell assays are often limited in terms of species translatability and predictability of human biology. This field urgently requires a push...
4.
Geisler L, Mohr R, Lambrecht J, Knorr J, Jann H, Loosen S, et al.
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445276
Neuroendocrine tumors (NETs) represent a tumor group that is both rare and heterogeneous. Prognosis is largely determined by the tumor grading and the site of the primary tumor and metastases....
5.
Lambrecht J, Porsch-Ozcurumez M, Best J, Jost-Brinkmann F, Roderburg C, Demir M, et al.
J Clin Med
. 2021 Aug;
10(15).
PMID: 34362181
(1) Background: Surveillance of at-risk patients for hepatocellular carcinoma (HCC) is highly necessary, as curative treatment options are only feasible in early disease stages. However, to date, screening of patients...
6.
Mohr R, Jost-Brinkmann F, Ozdirik B, Lambrecht J, Hammerich L, Loosen S, et al.
Front Immunol
. 2021 Apr;
12:652172.
PMID: 33859646
The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities...
7.
Lambrecht J, Tacke F
Front Immunol
. 2021 Feb;
11:634409.
PMID: 33633748
In the Western society, non-alcoholic fatty liver disease (NAFLD), characterized by the excessive accumulation of fat in the liver, represents the most common cause of chronic liver disease. If left...
8.
Mohr R, Ozdirik B, Lambrecht J, Demir M, Eschrich J, Geisler L, et al.
Int J Mol Sci
. 2021 Feb;
22(3).
PMID: 33540837
In almost all cases, hepatocellular carcinoma (HCC) develops as the endpoint of a sequence that starts with chronic liver injury, progresses to liver cirrhosis, and finally, over years and decades,...
9.
Hellberg T, Mohr R, Geisler L, Knorr J, Wree A, Demir M, et al.
PLoS One
. 2020 Dec;
15(12):e0244504.
PMID: 33382770
Background And Aims: MicroRNAs (miRNAs) are profoundly involved into the pathophysiology of manifold cancers. Recent data suggested a pivotal role of miRNAs as biomarkers in different biological processes including carcinogenesis....
10.
Wen Y, Lambrecht J, Ju C, Tacke F
Cell Mol Immunol
. 2020 Oct;
18(1):45-56.
PMID: 33041338
Macrophages, which are key cellular components of the liver, have emerged as essential players in the maintenance of hepatic homeostasis and in injury and repair processes in acute and chronic...